AU2002230708A1 - 6-0-carbamoyl ketolide derivatives of erythromycin useful as antibacterials - Google Patents

6-0-carbamoyl ketolide derivatives of erythromycin useful as antibacterials

Info

Publication number
AU2002230708A1
AU2002230708A1 AU2002230708A AU3070802A AU2002230708A1 AU 2002230708 A1 AU2002230708 A1 AU 2002230708A1 AU 2002230708 A AU2002230708 A AU 2002230708A AU 3070802 A AU3070802 A AU 3070802A AU 2002230708 A1 AU2002230708 A1 AU 2002230708A1
Authority
AU
Australia
Prior art keywords
compound
alkyl
mmol
hydrogen
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002230708A
Other languages
English (en)
Inventor
Todd C. Henninger
Xiaodong C. Xu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Ortho McNeil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc
Publication of AU2002230708A1 publication Critical patent/AU2002230708A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AU2002230708A 2000-12-06 2001-12-05 6-0-carbamoyl ketolide derivatives of erythromycin useful as antibacterials Abandoned AU2002230708A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US25154700P 2000-12-06 2000-12-06
US60251547 2000-12-06
US09/773,788 US6472372B1 (en) 2000-12-06 2001-02-01 6-O-Carbamoyl ketolide antibacterials
US09773788 2001-02-01
PCT/US2001/047530 WO2002046204A1 (en) 2000-12-06 2001-12-05 6-0-carbamoyl ketolide derivatives of erythromycin useful as antibacterials

Publications (1)

Publication Number Publication Date
AU2002230708A1 true AU2002230708A1 (en) 2002-06-18

Family

ID=26941686

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002230708A Abandoned AU2002230708A1 (en) 2000-12-06 2001-12-05 6-0-carbamoyl ketolide derivatives of erythromycin useful as antibacterials

Country Status (14)

Country Link
US (2) US6472372B1 (sh)
EP (1) EP1343798A1 (sh)
JP (1) JP2004515504A (sh)
KR (1) KR20040008115A (sh)
CN (1) CN1310934C (sh)
AU (1) AU2002230708A1 (sh)
BR (1) BR0116004A (sh)
CA (1) CA2431032A1 (sh)
HR (1) HRP20030468A2 (sh)
IL (1) IL156329A0 (sh)
MX (1) MXPA03005028A (sh)
RU (1) RU2003117027A (sh)
WO (1) WO2002046204A1 (sh)
YU (1) YU46303A (sh)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6472372B1 (en) * 2000-12-06 2002-10-29 Ortho-Mcneil Pharmaceuticals, Inc. 6-O-Carbamoyl ketolide antibacterials
US6825170B2 (en) * 2001-12-05 2004-11-30 Ortho-Mcneil Pharmaceutical, Inc. 6-O-acyl ketolide antibacterials
WO2003090761A1 (en) * 2002-04-25 2003-11-06 Abbott Laboratories 9-oxime macrolide antibacterials
JP2005531603A (ja) * 2002-05-31 2005-10-20 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ３−デスクラジノシル−６−ｏ−カルバモイルおよび６−ｏ−カルボノイルマクロライド抗菌剤
US20050250713A1 (en) * 2004-04-26 2005-11-10 Bin Zhu 11,12-Cyclic thiocarbamate macrolide antibacterial agents
WO2006080954A1 (en) * 2004-07-28 2006-08-03 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
WO2006046112A2 (en) * 2004-10-25 2006-05-04 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
WO2007060518A2 (en) * 2005-11-23 2007-05-31 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
US20090130225A1 (en) * 2005-11-23 2009-05-21 Anjan Chakrabarti Macrolides derivatives as antibacterial agents
JP2008044880A (ja) 2006-08-15 2008-02-28 Bayer Cropscience Ag 殺虫性イソオキサゾリン類
AU2007347798A1 (en) * 2006-08-30 2008-09-04 Long Island University Antimicrobial compositions
US8218847B2 (en) 2008-06-06 2012-07-10 Superdimension, Ltd. Hybrid registration method
GB201105633D0 (en) * 2011-04-01 2011-05-18 Norbrook Lab Ltd Antibotic compounds
CN103242239B (zh) * 2013-05-20 2015-09-23 洛阳师范学院 多取代嘧啶基苯甲醇及其制备方法
US9603668B2 (en) 2014-07-02 2017-03-28 Covidien Lp Dynamic 3D lung map view for tool navigation inside the lung
US9633431B2 (en) 2014-07-02 2017-04-25 Covidien Lp Fluoroscopic pose estimation
US9986983B2 (en) 2014-10-31 2018-06-05 Covidien Lp Computed tomography enhanced fluoroscopic system, device, and method of utilizing the same
US10674982B2 (en) 2015-08-06 2020-06-09 Covidien Lp System and method for local three dimensional volume reconstruction using a standard fluoroscope
US10716525B2 (en) 2015-08-06 2020-07-21 Covidien Lp System and method for navigating to target and performing procedure on target utilizing fluoroscopic-based local three dimensional volume reconstruction
US10702226B2 (en) 2015-08-06 2020-07-07 Covidien Lp System and method for local three dimensional volume reconstruction using a standard fluoroscope
US10575754B2 (en) 2015-09-23 2020-03-03 Covidien Lp Catheter having a sensor and an extended working channel
US11529190B2 (en) 2017-01-30 2022-12-20 Covidien Lp Enhanced ablation and visualization techniques for percutaneous surgical procedures
US11793579B2 (en) 2017-02-22 2023-10-24 Covidien Lp Integration of multiple data sources for localization and navigation
CN106928294A (zh) * 2017-03-22 2017-07-07 上海启雁实业有限公司 制备酮内酯大环内酯类抗生素的方法
US10699448B2 (en) 2017-06-29 2020-06-30 Covidien Lp System and method for identifying, marking and navigating to a target using real time two dimensional fluoroscopic data
EP3694412A4 (en) 2017-10-10 2021-08-18 Covidien LP SYSTEM AND METHOD FOR IDENTIFYING AND MARKING A TARGET IN A THREE-DIMENSIONAL FLUOROSCOPIC RECONSTRUCTION
US10930064B2 (en) 2018-02-08 2021-02-23 Covidien Lp Imaging reconstruction system and method
US10905498B2 (en) 2018-02-08 2021-02-02 Covidien Lp System and method for catheter detection in fluoroscopic images and updating displayed position of catheter
US11364004B2 (en) 2018-02-08 2022-06-21 Covidien Lp System and method for pose estimation of an imaging device and for determining the location of a medical device with respect to a target
US10872449B2 (en) 2018-05-02 2020-12-22 Covidien Lp System and method for constructing virtual radial ultrasound images from CT data and performing a surgical navigation procedure using virtual ultrasound images
US11705238B2 (en) 2018-07-26 2023-07-18 Covidien Lp Systems and methods for providing assistance during surgery
US11071591B2 (en) 2018-07-26 2021-07-27 Covidien Lp Modeling a collapsed lung using CT data
US11944388B2 (en) 2018-09-28 2024-04-02 Covidien Lp Systems and methods for magnetic interference correction
US11877806B2 (en) 2018-12-06 2024-01-23 Covidien Lp Deformable registration of computer-generated airway models to airway trees
US11045075B2 (en) 2018-12-10 2021-06-29 Covidien Lp System and method for generating a three-dimensional model of a surgical site
US11801113B2 (en) 2018-12-13 2023-10-31 Covidien Lp Thoracic imaging, distance measuring, and notification system and method
US11617493B2 (en) 2018-12-13 2023-04-04 Covidien Lp Thoracic imaging, distance measuring, surgical awareness, and notification system and method
US11357593B2 (en) 2019-01-10 2022-06-14 Covidien Lp Endoscopic imaging with augmented parallax
US11625825B2 (en) 2019-01-30 2023-04-11 Covidien Lp Method for displaying tumor location within endoscopic images
US11925333B2 (en) 2019-02-01 2024-03-12 Covidien Lp System for fluoroscopic tracking of a catheter to update the relative position of a target and the catheter in a 3D model of a luminal network
US11564751B2 (en) 2019-02-01 2023-01-31 Covidien Lp Systems and methods for visualizing navigation of medical devices relative to targets
US11744643B2 (en) 2019-02-04 2023-09-05 Covidien Lp Systems and methods facilitating pre-operative prediction of post-operative tissue function
US11819285B2 (en) 2019-04-05 2023-11-21 Covidien Lp Magnetic interference detection systems and methods
US11975157B2 (en) 2019-04-12 2024-05-07 Covidien Lp Method of manufacturing an elongated catheter having multiple sensors for three-dimensional location of the catheter
US11269173B2 (en) 2019-08-19 2022-03-08 Covidien Lp Systems and methods for displaying medical video images and/or medical 3D models
US11864935B2 (en) 2019-09-09 2024-01-09 Covidien Lp Systems and methods for pose estimation of a fluoroscopic imaging device and for three-dimensional imaging of body structures
US11931111B2 (en) 2019-09-09 2024-03-19 Covidien Lp Systems and methods for providing surgical guidance
US11627924B2 (en) 2019-09-24 2023-04-18 Covidien Lp Systems and methods for image-guided navigation of percutaneously-inserted devices
US11380060B2 (en) 2020-01-24 2022-07-05 Covidien Lp System and method for linking a segmentation graph to volumetric data
US11847730B2 (en) 2020-01-24 2023-12-19 Covidien Lp Orientation detection in fluoroscopic images
US11922581B2 (en) 2020-05-08 2024-03-05 Coviden Lp Systems and methods of controlling an operating room display using an augmented reality headset
US11701492B2 (en) 2020-06-04 2023-07-18 Covidien Lp Active distal tip drive
US11950950B2 (en) 2020-07-24 2024-04-09 Covidien Lp Zoom detection and fluoroscope movement detection for target overlay
CN112300221B (zh) * 2020-11-11 2022-04-15 艾美科健（中国）生物医药有限公司 一种加米霉素的合成方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8521402D0 (en) * 1985-08-28 1985-10-02 Beecham Group Plc Chemical compounds
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of the history of erythromycin
US5559256A (en) * 1992-07-20 1996-09-24 E. R. Squibb & Sons, Inc. Aminediol protease inhibitors
ES2218604T3 (es) 1995-11-08 2004-11-16 Abbott Laboratories Derivados triciclicos de eritromicina.
EP0906103A1 (en) * 1995-12-29 1999-04-07 Smithkline Beecham Corporation Vitronectin receptor antagonists
KR100523679B1 (ko) 1996-09-04 2005-10-26 아보트 러보러터리즈 항균 활성을 지닌 6-ｏ-치환된 케톨라이드
UA51730C2 (uk) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
WO1998009976A1 (fr) * 1996-09-06 1998-03-12 The Nisshin Oil Mills, Ltd. Derives de glycolipides sulfates et compositions medicinales obtenues a partir de ces derniers
HUP0000198A3 (en) 1996-11-27 2000-09-28 Taisho Pharmaceutical Co Ltd Erythromycin a derivatives
FR2757168B1 (fr) * 1996-12-12 1999-06-11 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
UA59384C2 (uk) * 1996-12-20 2003-09-15 Пфайзер, Інк. Похідні сульфонамідів та амідів як агоністи простагландину, фармацевтична композиція та способи лікування на їх основі
AR015986A1 (es) * 1997-10-29 2001-05-30 Abbott Lab Derivados de eritromicina puenteados en 6,11, composiciones farmaceuticas que los contienen, su uso para la manufactura de un medicamento y procedimientospara su preparacion
CO4990960A1 (es) * 1997-10-29 2000-12-26 Abbott Lab Derivados de cetolidos 2-halo-6-o sustituidos
AP1060A (en) 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
ATE340183T1 (de) 1999-04-16 2006-10-15 Kosan Biosciences Inc Antiinfektiöse makrolidderivate
US6458771B1 (en) 1999-04-16 2002-10-01 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
ATE250076T1 (de) 1999-06-07 2003-10-15 Abbott Lab 6-o-carbamat ketolide derivate
ES2306674T3 (es) 1999-12-02 2008-11-16 Abbott Laboratories Derivados cetolidos 6-o-alquil-2-nor-2-sustituidos.
EP1146051A3 (en) 2000-04-10 2001-10-31 Pfizer Products Inc. Erythromycin A derivatives
US6472372B1 (en) * 2000-12-06 2002-10-29 Ortho-Mcneil Pharmaceuticals, Inc. 6-O-Carbamoyl ketolide antibacterials

Also Published As

Publication number Publication date
RU2003117027A (ru) 2004-12-10
JP2004515504A (ja) 2004-05-27
CN1310934C (zh) 2007-04-18
EP1343798A1 (en) 2003-09-17
US6472372B1 (en) 2002-10-29
KR20040008115A (ko) 2004-01-28
US20030013663A1 (en) 2003-01-16
HRP20030468A2 (en) 2005-04-30
US6613747B2 (en) 2003-09-02
CA2431032A1 (en) 2002-06-13
US20020115620A1 (en) 2002-08-22
YU46303A (sh) 2006-05-25
CN1543472A (zh) 2004-11-03
WO2002046204A1 (en) 2002-06-13
MXPA03005028A (es) 2004-01-29
BR0116004A (pt) 2004-06-22
IL156329A0 (en) 2004-01-04

Similar Documents

Publication Publication Date Title
US6613747B2 (en) 6-O-carbamoyl ketolide antibacterials
US6124269A (en) 2-Halo-6-O-substituted ketolide derivatives
US6054435A (en) 6-O-substituted macrolides having antibacterial activity
AP1189A (en) C-4"-substituted macrolide derivatives.
US5656607A (en) Erythromycin derivatives
EP1027362B1 (en) 2-halo-6-o-substituted ketolide derivatives
US5780605A (en) 6,9-bridged erythromycin derivatives
US6407074B1 (en) C-4″-substituted macrolide derivatives
US6825170B2 (en) 6-O-acyl ketolide antibacterials
US6713455B2 (en) 6-O-carbamate-11,12-lacto-ketolide antimicrobials
US6140479A (en) Erythromycin a derivatives
US5439889A (en) Erythromycin derivatives
US6825172B2 (en) 3-descladinosyl-6-O-carbamoyl and 6-O-carbonoyl macrolide antibacterial agents
US6162794A (en) Erythromycin derivatives
US20050250713A1 (en) 11,12-Cyclic thiocarbamate macrolide antibacterial agents
WO2006047167A2 (en) 9 alkyl and 9 alkylidenyl 6-0 alkyl-11, 12 carbamate ketolide antimicrobials